Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to -$3.0 million.

  • BioRestorative Therapies' Profit After Tax fell 17837.94% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.7 million, marking a year-over-year decrease of 3155.19%. This contributed to the annual value of -$9.0 million for FY2024, which is 1360.86% up from last year.
  • As of Q3 2025, BioRestorative Therapies' Profit After Tax stood at -$3.0 million, which was down 17837.94% from -$2.7 million recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Profit After Tax ranged from a high of $4.8 million in Q3 2023 and a low of -$20.4 million during Q4 2021
  • In the last 5 years, BioRestorative Therapies' Profit After Tax had a median value of -$4.1 million in 2021 and averaged -$4.6 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 40034.88% in 2021, then soared by 20241.5% in 2023.
  • Quarter analysis of 5 years shows BioRestorative Therapies' Profit After Tax stood at -$20.4 million in 2021, then surged by 104.53% to $924920.0 in 2022, then plummeted by 349.1% to -$2.3 million in 2023, then grew by 28.09% to -$1.7 million in 2024, then tumbled by 83.39% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q3 2025, -$2.7 million for Q2 2025, and -$5.3 million during Q1 2025.